Literature DB >> 22907898

Clinical outcomes of transoral robotic supraglottic laryngectomy.

Enver Ozer1, Bianca Alvarez, Kiran Kakarala, Kasim Durmus, Theodoros N Teknos, Ricardo L Carrau.   

Abstract

BACKGROUND: Transoral, minimally invasive organ preservation surgeries are being increasingly used for laryngopharyngeal carcinomas to avoid the toxicities of combined chemotherapy and radiation therapy regimens. This study investigates the efficiency, safety, and functional outcomes of transoral robotic surgery (TORS) supraglottic laryngectomy.
METHODS: Patients with laryngeal cancer who underwent TORS supraglottic laryngectomy and participated in a prospective TORS study between 2008 and 2011 at an academic medical center are presented.
RESULTS: Thirteen of 126 patients underwent TORS supraglottic laryngectomy for laryngeal cancer. Average robotic operative time and estimated blood loss were 25.3 minutes and 15.4 mL, respectively. Negative surgical margins were achieved in all patients. Eleven patients were started on an oral diet within 24 hours of surgery with no evidence of immediate airway compromise. Two patients (15.4%) received adjuvant radiation therapy based on pathology.
CONCLUSION: In this preliminary study, TORS supraglottic laryngectomy was a safe procedure with good functional outcomes.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  head and neck cancer; supraglottic laryngectomy; transoral robotic surgery

Mesh:

Year:  2012        PMID: 22907898     DOI: 10.1002/hed.23101

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  20 in total

1.  Retroauricular endoscopic and robotic versus conventional neck dissection for oral cancer.

Authors:  Renan Bezerra Lira; Thiago Celestino Chulam; Genival Barbosa de Carvalho; Willem Hans Schreuder; Yoon Woo Koh; Eun Chang Choi; Luiz Paulo Kowalski
Journal:  J Robot Surg       Date:  2017-05-04

2.  Understanding contraindications for transoral robotic surgery (TORS) for oropharyngeal cancer.

Authors:  Gregory S Weinstein; Bert W O'Malley; Alessandra Rinaldo; Carl E Silver; Jochen A Werner; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-20       Impact factor: 2.503

Review 3.  Safe implementation of retroauricular robotic and endoscopic neck surgery in South America.

Authors:  Renan Bezerra Lira; Thiago Celestino Chulam; Luiz Paulo Kowalski
Journal:  Gland Surg       Date:  2017-06

4.  Cost comparison of open approach, transoral laser microsurgery and transoral robotic surgery for partial and total laryngectomies.

Authors:  Manon Dombrée; Ralph Crott; Georges Lawson; Pascal Janne; Annick Castiaux; Bruno Krug
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-07       Impact factor: 2.503

5.  How often parapharyngeal space is encountered in TORS oropharynx cancer resection.

Authors:  Cuneyt Kucur; Kasim Durmus; Theodoros N Teknos; Enver Ozer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-21       Impact factor: 2.503

Review 6.  Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes.

Authors:  Arlene A Forastiere; Randal S Weber; Andy Trotti
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

Review 7.  Minimally Invasive Procedures for Laryngeal Carcinoma: Transoral Endoscopic Laser and Transoral Robotic Surgery.

Authors:  Özgül Topal
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01

Review 8.  Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?

Authors:  J Kenneth Byrd; Robert L Ferris
Journal:  Curr Treat Options Oncol       Date:  2016-06

Review 9.  Transoral Robotic Surgery.

Authors:  Karthik N Rao; Kranthi Kumar Gangiti
Journal:  Indian J Surg Oncol       Date:  2021-09-09

10.  Stage Migration and Survival Trends in Laryngeal Cancer.

Authors:  Michael M Li; Songzhu Zhao; Antoine Eskander; Chandler Rygalski; Guy Brock; Anuraag S Parikh; Catherine T Haring; Brian Swendseid; Kevin Y Zhan; Carol R Bradford; Theodoros N Teknos; Ricardo L Carrau; Kyle K VanKoevering; Nolan B Seim; Matthew O Old; James W Rocco; Sidharth V Puram; Stephen Y Kang
Journal:  Ann Surg Oncol       Date:  2021-07-15       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.